<!DOCTYPE html>

<html lang="en" data-theme="light">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Skeletal Muscle Relaxants - Essentials of Medical Pharmacology</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap"
        rel="stylesheet">

    <link rel="stylesheet" href="../styles/main.css">

    <script>
        MathJax = {
            tex: {
                inlineMath: [['$', '$'], ['\\(', '\\)']],
                displayMath: [['$$', '$$'], ['\\[', '\\]']],
                processEscapes: true,
                processEnvironments: true
            },
            svg: { fontCache: 'global' },
            options: {
                skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
            }
        };
    </script>

    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>

</head>

<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Floating TOC -->

    <nav class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span> Table of Contents
        </div>
        <ul class="floating-toc-list">
            <li><a href="#classification">Classification</a></li>
            <li><a href="#neuromuscular-blockers">Neuromuscular Blockers</a></li>
            <li><a href="#succinylcholine">Succinylcholine</a></li>
            <li><a href="#competitive-blockers">Competitive Blockers</a></li>
            <li><a href="#reversal">Reversal of Block</a></li>
            <li><a href="#dantrolene">Directly Acting (Dantrolene)</a></li>
            <li><a href="#central-relaxants">Centrally Acting Relaxants</a></li>
            <li><a href="#case-study">Problem Directed Study</a></li>
        </ul>
    </nav>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üí™</span>
                        <span>Topic 26</span>
                    </div>
                    <h1 class="document-title">Skeletal Muscle Relaxants</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Peripheral Nervous System</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>40 min read</span>
                        </div>
                    </div>
                </header>
                <main id="main-content" class="content-wrapper">
                    <!-- Section 1: Classification -->
                    <section class="content-section" id="classification">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìä</span>
                                Classification
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Skeletal muscle relaxants are drugs that reduce muscle tone or cause paralysis. They are
                                broadly classified based on their site of action.</p>

                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>1. Peripherally Acting</h4>
                                    <p>Act at the neuromuscular junction (NMJ) or directly on the muscle.</p>
                                    <ul>
                                        <li><strong>Neuromuscular Blockers:</strong> Used for surgery/ICU.
                                            <ul>
                                                <li><em>Nondepolarizing (Competitive):</em> d-Tubocurarine, Pancuronium,
                                                    Vecuronium, Rocuronium, Atracurium.</li>
                                                <li><em>Depolarizing:</em> Succinylcholine (SCh).</li>
                                            </ul>
                                        </li>
                                        <li><strong>Directly Acting:</strong> Dantrolene.</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>2. Centrally Acting</h4>
                                    <p>Act in the cerebrospinal axis to reduce tone (spasticity). Used for chronic
                                        neurological diseases or acute muscle spasms.</p>
                                    <ul>
                                        <li>Diazepam</li>
                                        <li>Baclofen</li>
                                        <li>Tizanidine</li>
                                        <li>Methocarbamol</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 2: Neuromuscular Blockers -->
                    <section class="content-section" id="neuromuscular-blockers">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ö°</span>
                                Neuromuscular Blockers: Mechanism
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>These drugs interfere with the action of Acetylcholine (ACh) at the Nicotinic ($N_M$)
                                receptors on the motor end plate.</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Feature</th>
                                            <th>Competitive (e.g., Curare)</th>
                                            <th>Depolarizing (e.g., SCh)</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Mechanism</strong></td>
                                            <td>Competes with ACh for $N_M$ receptors. No intrinsic activity. Prevents
                                                depolarization.</td>
                                            <td>Stimulates $N_M$ receptors (agonist) causing persistent depolarization
                                                $\rightarrow$ desensitization (Phase I block).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Initial Effect</strong></td>
                                            <td>Flaccid paralysis immediately.</td>
                                            <td><strong>Fasciculations</strong> (twitching) followed by paralysis.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Neostigmine Effect</strong></td>
                                            <td><strong>Reverses block</strong> (Increases ACh which displaces blocker).
                                            </td>
                                            <td><strong>Potentiates block</strong> (Inhibits ACh breakdown, worsening
                                                depolarization).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Tetanic Stimulation</strong></td>
                                            <td>Shows <strong>Fade</strong> (Post-tetanic potentiation present).</td>
                                            <td>Sustained contraction (No fade in Phase I).</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </section>

                    <!-- Section 3: Succinylcholine -->
                    <section class="content-section" id="succinylcholine">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ö†Ô∏è</span>
                                Succinylcholine (SCh)
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>The only depolarizing blocker in clinical use. It consists of two ACh molecules joined
                                together.</p>

                            <h3>Features</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Pharmacokinetics:</strong> Extremely short duration (5-10
                                    min) because it is rapidly hydrolysed by <strong>Plasma
                                        Pseudocholinesterase</strong>.</li>
                                <li class="list-item"><strong>Primary Use:</strong> <strong>Endotracheal
                                        Intubation</strong> (rapid onset &lt; 1 min, short duration).</li>
                            </ul>

                            <div class="callout callout--danger">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ò£Ô∏è</span>
                                    <h4 class="callout-title">Adverse Effects & Toxicities</h4>
                                </div>
                                <div class="callout-content">
                                    <ul>
                                        <li><strong>Prolonged Apnoea (Scoline Apnoea):</strong> In patients with
                                            atypical/deficient pseudocholinesterase (genetic). Treatment is fresh blood
                                            transfusion.</li>
                                        <li><strong>Hyperkalaemia:</strong> SCh causes $K^+$ efflux from muscles. Can
                                            cause cardiac arrest in burns, trauma, or nerve injury patients.
                                            <strong>Contraindicated in burns > 24 hrs.</strong></li>
                                        <li><strong>Muscle Pain:</strong> Post-operative myalgia due to initial
                                            fasciculations.</li>
                                        <li><strong>Malignant Hyperthermia:</strong> Rare genetic disorder involving
                                            uncontrolled $Ca^{2+}$ release from sarcoplasmic reticulum. Treatment:
                                            <strong>Dantrolene</strong>.</li>
                                        <li><strong>Increased Intraocular/Intragastric Pressure.</strong></li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 4: Competitive Blockers -->
                    <section class="content-section" id="competitive-blockers">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Competitive Blockers
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Used for muscle relaxation during surgery (maintenance) and in ICU.</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Drug</th>
                                            <th>Duration</th>
                                            <th>Elimination</th>
                                            <th>Special Features</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>d-Tubocurarine</strong></td>
                                            <td>Long</td>
                                            <td>Renal</td>
                                            <td>Releases <strong>Histamine</strong> (Hypotension, Bronchospasm).
                                                Ganglion block. (Obsolete).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Pancuronium</strong></td>
                                            <td>Long</td>
                                            <td>Renal</td>
                                            <td><strong>Vagolytic</strong> (Causes Tachycardia, hypertension).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Vecuronium</strong></td>
                                            <td>Intermediate</td>
                                            <td>Hepatic/Bile</td>
                                            <td><strong>Cardiovascular stability</strong>. No histamine release.
                                                Preferred in cardiac patients.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Atracurium</strong></td>
                                            <td>Intermediate</td>
                                            <td><strong>Hofmann Elimination</strong></td>
                                            <td>Safe in <strong>Renal & Hepatic Failure</strong>. Releases Histamine.
                                                Metabolite Laudanosine can cause seizures.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Cisatracurium</strong></td>
                                            <td>Intermediate</td>
                                            <td>Hofmann</td>
                                            <td>Isomer of Atracurium. <strong>No histamine release</strong>. Potent.
                                                Drug of choice in organ failure.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Rocuronium</strong></td>
                                            <td>Intermediate</td>
                                            <td>Hepatic</td>
                                            <td><strong>Rapid onset</strong> (60-90 sec). Alternative to SCh for
                                                intubation.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </section>

                    <!-- Section 5: Reversal -->
                    <section class="content-section" id="reversal">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üîÑ</span>
                                Reversal of Block
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Standard Reversal</h3>
                            <p><strong>Neostigmine</strong> (Anticholinesterase) is used to reverse competitive block at
                                the end of surgery. It increases ACh levels which displace the blocker.</p>
                            <p><strong>Atropine</strong> or Glycopyrrolate must be given prior to Neostigmine to prevent
                                muscarinic side effects (bradycardia, salivation).</p>

                            <h3>Sugammadex</h3>
                            <p>A novel selective relaxant binding agent (cyclodextrin). It encapsulates
                                <strong>Rocuronium</strong> or Vecuronium molecules in plasma, terminating their action
                                immediately. Does not involve cholinergic mechanisms (no atropine needed). Useful for
                                rapid reversal of deep block.</p>
                        </div>
                    </section>

                    <!-- Section 6: Dantrolene -->
                    <section class="content-section" id="dantrolene">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üõë</span>
                                Directly Acting: Dantrolene
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Mechanism:</strong> Uncouples excitation-contraction. Acts on <strong>Ryanodine
                                    Receptor (RyR1)</strong> calcium channels in the sarcoplasmic reticulum of skeletal
                                muscle and prevents intracellular $Ca^{2+}$ release.</p>
                            <p><strong>Uses:</strong></p>
                            <ul>
                                <li><strong>Malignant Hyperthermia:</strong> Drug of choice (i.v.).</li>
                                <li><strong>Spasticity:</strong> Paraplegia, hemiplegia, cerebral palsy (Oral). Reduces
                                    muscle power (weakness is a side effect).</li>
                            </ul>
                            <p><strong>Adverse Effects:</strong> Hepatotoxicity (dose dependent), weakness, sedation.
                            </p>
                        </div>
                    </section>

                    <!-- Section 7: Centrally Acting -->
                    <section class="content-section" id="central-relaxants">
                        <div class="section-header">
                            <div class="section-number">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß†</span>
                                Centrally Acting Muscle Relaxants
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Reduce muscle tone without abolishing voluntary power. Act on spinal/supraspinal
                                polysynaptic reflexes.</p>

                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Diazepam:</strong> Facilitates GABA-A action. Sedative.
                                    Used for muscle spasms, tetanus.</li>
                                <li class="list-item"><strong>Baclofen:</strong> Selective <strong>GABA-B
                                        agonist</strong>. Hyperpolarizes neurones ($K^+$ efflux). Less sedative. Drug of
                                    choice for spinal spasticity (MS, ALS, spinal injury).</li>
                                <li class="list-item"><strong>Tizanidine:</strong> Central $\alpha_2$ adrenergic agonist
                                    (congener of clonidine). Inhibits release of excitatory amino acids. Used in
                                    spasticity. Side effects: Dry mouth, drowsiness, hypotension.</li>
                                <li class="list-item"><strong>Methocarbamol/Chlorzoxazone:</strong> Used for acute
                                    muscle spasms (strains, backache).</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 8: Case Study -->
                    <section class="content-section" id="case-study">
                        <div class="section-header">
                            <div class="section-number">08</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü§î</span>
                                Problem Directed Study
                            </h2>
                        </div>

                        <div class="content-card">
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìù</span>
                                    <h4 class="callout-title">Case 25.1</h4>
                                </div>
                                <div class="callout-content">
                                    <p>A 30-year lady brought to emergency with <strong>40% burn injury</strong> has to
                                        be operated under general anaesthesia.</p>
                                    <p><strong>(a) Preferred Muscle Relaxant:</strong> <strong>Rocuronium</strong> or
                                        <strong>Vecuronium</strong>.</p>
                                    <p><strong>(b) Reason:</strong> <strong>Succinylcholine is Contraindicated.</strong>
                                        In patients with extensive burns (and massive tissue injury), SCh causes massive
                                        efflux of potassium from muscles, leading to <strong>severe
                                            hyperkalaemia</strong> and cardiac arrest. This risk is maximal from 24
                                        hours to 1-2 years after injury. Rocuronium provides rapid onset for intubation
                                        without this risk.</p>
                                </div>
                            </div>
                        </div>
                    </section>

                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="topic-25-calcium.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Calcium & Bone Drugs</div>
                        </a>

                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>26</span>
                                <span class="progress-separator">/</span>
                                <span>27</span>
                            </div>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 96%;"></div>
                            </div>
                            <div class="progress-label">Topic Progress</div>
                        </div>

                        <a href="topic-27-local-anaesthetics.html"
                            class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Local Anaesthetics</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <script src="../js/theme.js"></script>

    <script src="../js/navigation.js"></script>

    <script src="../js/interactions.js"></script>

</body>

</html>